These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 20569441)
1. Activation of endogenous p53 by combined p19Arf gene transfer and nutlin-3 drug treatment modalities in the murine cell lines B16 and C6. Merkel CA; da Silva Soares RB; de Carvalho AC; Zanatta DB; Bajgelman MC; Fratini P; Costanzi-Strauss E; Strauss BE BMC Cancer; 2010 Jun; 10():316. PubMed ID: 20569441 [TBL] [Abstract][Full Text] [Related]
2. Combined p19Arf and interferon-beta gene transfer enhances cell death of B16 melanoma in vitro and in vivo. Merkel CA; Medrano RF; Barauna VG; Strauss BE Cancer Gene Ther; 2013 May; 20(5):317-25. PubMed ID: 23618951 [TBL] [Abstract][Full Text] [Related]
3. Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21). Drakos E; Singh RR; Rassidakis GZ; Schlette E; Li J; Claret FX; Ford RJ; Vega F; Medeiros LJ Leukemia; 2011 May; 25(5):856-67. PubMed ID: 21394100 [TBL] [Abstract][Full Text] [Related]
4. Distinct Roles of Direct Transduction Versus Exposure to the Tumor Secretome on Murine Endothelial Cells After Melanoma Gene Therapy with Interferon-β and p19Arf. Vieira IL; Tamura RE; Hunger A; Strauss BE J Interferon Cytokine Res; 2019 Apr; 39(4):246-258. PubMed ID: 30848981 [TBL] [Abstract][Full Text] [Related]
6. Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells. Miyachi M; Kakazu N; Yagyu S; Katsumi Y; Tsubai-Shimizu S; Kikuchi K; Tsuchiya K; Iehara T; Hosoi H Clin Cancer Res; 2009 Jun; 15(12):4077-84. PubMed ID: 19509161 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas. Künkele A; De Preter K; Heukamp L; Thor T; Pajtler KW; Hartmann W; Mittelbronn M; Grotzer MA; Deubzer HE; Speleman F; Schramm A; Eggert A; Schulte JH Neuro Oncol; 2012 Jul; 14(7):859-69. PubMed ID: 22591662 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53. Van Maerken T; Ferdinande L; Taildeman J; Lambertz I; Yigit N; Vercruysse L; Rihani A; Michaelis M; Cinatl J; Cuvelier CA; Marine JC; De Paepe A; Bracke M; Speleman F; Vandesompele J J Natl Cancer Inst; 2009 Nov; 101(22):1562-74. PubMed ID: 19903807 [TBL] [Abstract][Full Text] [Related]
9. Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma. de Lange J; Ly LV; Lodder K; Verlaan-de Vries M; Teunisse AF; Jager MJ; Jochemsen AG Oncogene; 2012 Mar; 31(9):1105-16. PubMed ID: 21765463 [TBL] [Abstract][Full Text] [Related]
10. MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro. Wang J; Zheng T; Chen X; Song X; Meng X; Bhatta N; Pan S; Jiang H; Liu L J Gastroenterol Hepatol; 2011 Feb; 26(2):371-7. PubMed ID: 21261729 [TBL] [Abstract][Full Text] [Related]
11. Potent in vitro and in vivo antitumor effects of MDM2 inhibitor nutlin-3 in gastric cancer cells. Endo S; Yamato K; Hirai S; Moriwaki T; Fukuda K; Suzuki H; Abei M; Nakagawa I; Hyodo I Cancer Sci; 2011 Mar; 102(3):605-13. PubMed ID: 21205074 [TBL] [Abstract][Full Text] [Related]
12. Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53. He T; Guo J; Song H; Zhu H; Di X; Min H; Wang Y; Chen G; Dai W; Ma J; Sun X; Ma J Pathol Oncol Res; 2018 Jan; 24(1):75-81. PubMed ID: 28341911 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma. Drakos E; Thomaides A; Medeiros LJ; Li J; Leventaki V; Konopleva M; Andreeff M; Rassidakis GZ Clin Cancer Res; 2007 Jun; 13(11):3380-7. PubMed ID: 17545546 [TBL] [Abstract][Full Text] [Related]
14. Activation of p53 by Nutlin-3a, an antagonist of MDM2, induces apoptosis and cellular senescence in adult T-cell leukemia cells. Hasegawa H; Yamada Y; Iha H; Tsukasaki K; Nagai K; Atogami S; Sugahara K; Tsuruda K; Ishizaki A; Kamihira S Leukemia; 2009 Nov; 23(11):2090-101. PubMed ID: 19710698 [TBL] [Abstract][Full Text] [Related]
15. Nutlin-3 inhibits the NFkappaB pathway in a p53-dependent manner: implications in lung cancer therapy. Dey A; Wong ET; Bist P; Tergaonkar V; Lane DP Cell Cycle; 2007 Sep; 6(17):2178-85. PubMed ID: 17786042 [TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of nutlin-induced apoptosis in multiple myeloma: evidence for p53-transcription-dependent and -independent pathways. Saha MN; Jiang H; Chang H Cancer Biol Ther; 2010 Sep; 10(6):567-78. PubMed ID: 20595817 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the antitumor effects of an MDM2 inhibitor, nutlin-3, in feline lymphoma cell lines with or without p53 mutation. Mochizuki H; Goto-Koshino Y; Sato M; Fujino Y; Ohno K; Tsujimoto H Vet Immunol Immunopathol; 2012 Jun; 147(3-4):187-94. PubMed ID: 22578852 [TBL] [Abstract][Full Text] [Related]
18. MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway. Zauli G; Rimondi E; Corallini F; Fadda R; Capitani S; Secchiero P J Bone Miner Res; 2007 Oct; 22(10):1621-30. PubMed ID: 17592964 [TBL] [Abstract][Full Text] [Related]
19. Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity. Sriraman A; Radovanovic M; Wienken M; Najafova Z; Li Y; Dobbelstein M Oncotarget; 2016 May; 7(22):31623-38. PubMed ID: 27183917 [TBL] [Abstract][Full Text] [Related]
20. Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells. Secchiero P; Zerbinati C; di Iasio MG; Melloni E; Tiribelli M; Grill V; Zauli G Curr Drug Metab; 2007 May; 8(4):395-403. PubMed ID: 17504227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]